March 28, 2016 Issue | Chemical & Engineering News
 
Copyright © 2016 American Chemical Society
 

March 28, 2016 Issue

Volume 94, Issue 13
09413-cov-cover
March 28, 2016 Issue, Vol. 94 | Iss. 13
Scientists are testing whether drugs that alter consciousness can treat intractable mental health conditions
By Jyllian Kemsley
(pp. 28-32)
Features
Business
Despite an economic slowdown in China, expectations are high for 2016 (pp. 18-19)
Education
Teachers say yes, but most of the problems aren’t new (pp. 24-25)
Back Issues
 

News of the Week

Graphene patch could help patients manage diabetes

Wearable, dual-function device monitors glucose in sweat and delivers drugs through skin
(p.5)

Chemists cut in half the number of steps needed to synthesize phorbol

Nineteen-step enantioselective synthesis opens up avenues to previously inaccessible analogs of this biologically active compound
(p.6)

Researcher Thea Ekins-Coward loses arm in University of Hawaii explosion

Incident involved mix of hydrogen, carbon dioxide, and oxygen gases
(p.6)

Carbon dioxide hydrogenated to methanol on large scale

Supported indium oxide catalyst could boost lab-scale process to an industrial level
(p.7)

New model could help detect illicit nuclear tests

Simulations predict isotope ratios of gases that leak from underground test sites
(p.7)

Researchers create living cells containing the smallest genome yet

Minimal bacterial genome contains 473 genes, 149 of which still have unknown functions
(p.8)

Z-alkenyl halides made easy

Tough-to-prepare motif succumbs to metathesis
(p.8)

Former employees seek to acquire Affymetrix

$1.6 billion bid for genetic analysis firm attempts to edge out Thermo Fisher
(p.12)

Scripps sues sequencing leader Illumina

Scripps Research Institute alleges Illumina’s sequencing technology infringes patent
(p.12)

BMS to buy start-up Padlock

Deal worth up to $600 million adds small molecules for autoimmune disease
(p.13)

Dyson invests big in batteries

Maker of cordless vacuum cleaners to spend $1.4 billion on technology development
(p.13)

Merck, Harvard sign hefty drug pact

Cancer compounds from chemist Matthew Shair’s lab bring in $20 million
(p.13)

Second chance for rejected grants

OnPar Project offers top NIH proposals to private funders
(p.16)
 

Departments

09413-bus1-pitt0854cxd

Business

Despite an economic slowdown in China, expectations are high for 2016
(pp. 18-19)
New instruments under development could become the marijuana equivalent of the breathalyzer
(pp. 20-21)
With production of farnesene scaled up, profitability is the firm’s next hurdle
(pp. 26-27)

Career & Employment

Flexible scheduling is key to maintaining a sense of balance for many chemists and chemical engineers
(pp. 22-23)

Editor's Page